Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Idoxifene

😃Good
Catalog No. T14883Cas No. 116057-75-1
Alias CB7432

Idoxifene (CB7432) is a selective and tissue-specific estrogen receptor modulator (SERM) that reduces collagen and malondialdehyde (MDA) levels in rat liver, exhibiting anti-fibrotic effects.

Idoxifene

Idoxifene

😃Good
Purity: 100%
Catalog No. T14883Alias CB7432Cas No. 116057-75-1
Idoxifene (CB7432) is a selective and tissue-specific estrogen receptor modulator (SERM) that reduces collagen and malondialdehyde (MDA) levels in rat liver, exhibiting anti-fibrotic effects.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$68-In Stock
5 mg$163-In Stock
10 mg$289-In Stock
25 mg$619-In Stock
50 mg$1,070-In Stock
100 mg$1,820-In Stock
1 mL x 10 mM (in DMSO)$189-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:100%
Appearance:Solid
Color:Gray
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Idoxifene (CB7432) is a selective and tissue-specific estrogen receptor modulator (SERM) that reduces collagen and malondialdehyde (MDA) levels in rat liver, exhibiting anti-fibrotic effects.
In vitro
In vascular smooth muscle cells, Idoxifene inhibits Angiotensin II-induced reactive oxygen species (ROS) production [1].
In cultured activated hepatic stellate cells, Idoxifene dose-dependently inhibits activation and proliferation while time-dependently inducing apoptosis [1].
Idoxifene acts as an estrogen receptor agonist on osteoblasts in bone and exhibits weak agonist activity in human endometrial cells. Idoxifene and estradiol (E2) protect hepatocytes from inflammatory cell damage by inhibiting NF-κB activation [2].
In vivo
Following DMN treatment, rats administered daily intraperitoneal estradiol (0.5 mg/kg) alongside Idoxifene (0.1 and 0.5 mg/kg; oral) for 3 days exhibited dose-dependent reductions in liver collagen and malondialdehyde (MDA) levels, demonstrating antifibrotic effects [2].
SynonymsCB7432
Chemical Properties
Molecular Weight523.45
FormulaC28H30INO
Cas No.116057-75-1
SmilesC(=C(/CC)\C1=CC=CC=C1)(\C2=CC=C(OCCN3CCCC3)C=C2)/C4=CC=C(I)C=C4
Relative Density.1.329g/cm3
Storage & Solubility Information
Storagekeep away from moisture,keep away from direct sunlight | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (76.42 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9104 mL9.5520 mL19.1040 mL95.5201 mL
5 mM0.3821 mL1.9104 mL3.8208 mL19.1040 mL
10 mM0.1910 mL0.9552 mL1.9104 mL9.5520 mL
20 mM0.0955 mL0.4776 mL0.9552 mL4.7760 mL
50 mM0.0382 mL0.1910 mL0.3821 mL1.9104 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Idoxifene | purchase Idoxifene | Idoxifene cost | order Idoxifene | Idoxifene chemical structure | Idoxifene in vivo | Idoxifene in vitro | Idoxifene formula | Idoxifene molecular weight